WestCap led the Series B round with participation from Citi, EJF Capital and Optiver PSI.
"We believe that lending your stocks, bonds and ETFs is a basic ownership right that should be made available to all. As private investor participation increases in capital markets, we are leveling the playing field so that private investors, through their brokers and banks, can benefit from income generating solutions that have been largely restricted to big financial institutions. We are humbled by this vote of confidence from such a strong group of investors. This partnership enables us to accelerate our global growth plans and scale, expand our offering faster and realize our vision of opening up securities lending to every investor worldwide."
The pre-seed round was co-led by IQ Capital and Ahren Innovation Capital to support team expansion and technology validation.
"Our ability to take a sample from someone with an unknown infection and answer the open question 'what do they have?' within a minute is a gamechanger for infection diagnosis and treatment. We’ll start with respiratory viruses and expand from there. In parallel, we’ll be simplifying the workflow to move the test from the lab to point of care, which will represent a step change in the availability and cost of infectious disease diagnostics worldwide."
HydrogenOne Capital Growth led the Series B round with support from IP Group, Parkwalk Advisors, BGF, and the UCL Technology Fund.
"Hydrogen, through its green production from electrolysis or its use in fuel cells to provide clean power, is critical for the transition to net zero. Bramble Energy brings a fundamentally different approach to these technologies, unlocking the deployment of hydrogen faster, more flexibly and at scale. We are delighted to contribute substantially to this significant funding round which will take Bramble to the next stage."
The investment round was led by Atomico and will support international expansion.
"The fertility care model as we know it today is broken because the gap between those who want access to fertility treatments and those who can afford access is greater than ever. Three out of four people who seek fertility treatment never start because they believe the financial burden would be too large,"
The Series C financing round was led by Singular with participation from dmg ventures, Lansdowne Partners, Kathaka, Felix Capital, and Beringea.
"Taymoor and the Papier team have completely reinvented stationery for today’s consumer. They’ve taken the traditional charm, sophistication, and personalised touch of the offline paper world, and merged it with a seamless, tech-driven consumer experience and production process. I’ve been so impressed with the team’s vision, ambition, and consumer-first values. We at Singular are thrilled to partner with Papier on taking this world-class brand to even greater heights."
